The recombinant protein is typically produced in E. coli with an N-terminal His tag for affinity purification . Key production parameters include:
Expression Host: E. coli (BL21 or similar strains).
Tag: Hexahistidine (His-tag) for immobilized metal ion affinity chromatography (IMAC) .
Drug Development: AtpE is a validated target for novel antibiotics (e.g., diarylquinolines) due to its conserved structure in pathogenic bacteria .
Structural Studies: Recombinant AtpE facilitates cryo-EM and X-ray crystallography studies of c-ring architecture .
| Mutation | Effect on Drug Binding | Pathogen Affected |
|---|---|---|
| V48I | Steric hindrance reduces inhibitor efficacy | Streptococcus pneumoniae |
| V60A | Alters proton channel conformation | Staphylococcus aureus |
KEGG: bsu:BSU36860
STRING: 224308.Bsubs1_010100019931